LakeShore Biopharma
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $135,527 | $168,705 | $96,818 | $176,274 |
Gross Profit | 34,408 | 133,806 | 79,311 | 141,594 |
EBITDA | -82,725 | -72,354 | -98,475 | -62,100 |
EBIT | -93,286 | -81,508 | -113,204 | -63,361 |
Net Income | -181,410 | -80,152 | -104,980 | -69,542 |
Net Change In Cash | 135,527 | 168,705 | 96,818 | 176,274 |
Cash | 222,659 | 259,905 | 94,749 | |
Basic Shares | 14,851 | 93,058 | 93,058 | 93,058 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $573,418 | $687,201 | $502,949 | $257,015 |
Gross Profit | 455,729 | 533,840 | 385,883 | 197,359 |
EBITDA | -368,663 | -76,800 | -67,195 | -116,776 |
EBIT | -410,848 | -113,487 | -98,349 | -144,682 |
Net Income | -433,464 | -145,479 | -545 | -191,826 |
Net Change In Cash | 573,418 | 687,201 | 502,949 | 257,015 |
Free Cash Flow | -339,480 | -239,519 | -299,545 | -351,494 |
Cash | 246,351 | 370,108 | 885 | 390,457 |
Basic Shares | 106,923 | 77,421 | 29,500 | 28,750 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.34 |
2024-03-31 | -$0.19 |
2023-12-31 | -$0.11 |
2023-09-30 | -$0.16 |
